Security Snapshot

ISHARES TR - U.S. INSRNCE ETF (IAK) Institutional Ownership

CUSIP: 464288786

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

147

Shares (Excl. Options)

1,860,269

Price

$136.15

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / U.S. INSRNCE ETF
Symbol
IAK
Price per share
$131.68
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,860,269
Total reported value
$253,275,087
% of total 13F portfolios
0%
Share change
-1,426,748
Value change
-$193,707,368
Number of holders
147
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • IAK - ISHARES TR - U.S. INSRNCE ETF is tracked under CUSIP 464288786.
  • 147 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 147 to 98 between Q4 2025 and Q1 2026.
  • Reported value moved from $253,275,087 to $117,338,293.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 147 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 464288786?
CUSIP 464288786 identifies IAK - ISHARES TR - U.S. INSRNCE ETF in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 147 institutional investors reported holding 1,860,269 shares of ISHARES TR - U.S. INSRNCE ETF (IAK).

Institutional Holders of ISHARES TR - U.S. INSRNCE ETF (IAK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 914,636 $117,338,293 -$41,398,754 $128.29 98
2025 Q4 1,860,269 $253,275,087 -$193,707,368 $136.15 147
2025 Q3 3,450,291 $462,288,605 -$56,538,345 $134.03 157
2025 Q2 3,894,134 $522,804,140 +$33,336,167 $134.46 173
2025 Q1 3,762,207 $517,675,938 -$7,156,294 $137.81 164
2024 Q4 3,775,405 $477,655,677 +$12,701,478 $126.47 155
2024 Q3 3,664,176 $471,721,815 +$15,823,568 $129.05 147
2024 Q2 3,529,353 $398,589,550 -$34,757,061 $112.92 133
2024 Q1 3,764,656 $441,843,702 +$109,437,023 $117.39 110
2023 Q4 2,878,633 $288,241,301 +$27,380,518 $100.12 100
2023 Q3 2,599,052 $238,208,693 -$26,684,794 $91.65 80
2023 Q2 2,893,780 $254,325,941 -$75,694,988 $87.89 79
2023 Q1 3,762,462 $322,171,235 -$44,814,450 $85.62 92
2022 Q4 4,248,346 $388,304,484 +$129,853,337 $91.40 94
2022 Q3 2,771,859 $219,200,397 +$32,708,422 $79.09 75
2022 Q2 2,460,194 $204,158,480 +$110,027,671 $82.97 69
2022 Q1 1,059,808 $96,671,770 +$65,871,024 $91.20 53
2021 Q4 325,787 $27,273,000 +$4,548,456 $83.57 35
2021 Q3 260,489 $20,474,000 -$4,045,210 $78.21 31
2021 Q2 312,674 $24,198,000 -$469,259 $77.40 35
2021 Q1 321,241 $23,969,603 -$164,817 $74.26 32
2020 Q4 324,632 $21,941,000 -$7,879,490 $67.51 35
2020 Q3 448,797 $25,095,762 +$89,586 $55.74 34
2020 Q2 428,092 $23,550,344 -$4,294,379 $55.02 35
2020 Q1 527,119 $26,126,788 -$2,296,277 $49.57 32
2019 Q4 554,058 $39,522,676 -$3,973,363 $71.33 43
2019 Q3 640,492 $46,131,459 -$4,477 $72.03 42
2019 Q2 640,672 $45,303,253 -$3,165,484 $70.71 38
2019 Q1 688,168 $43,781,018 -$11,422,425 $63.62 39
2018 Q4 869,369 $50,173,654 +$17,593,151 $57.71 38
2018 Q3 562,113 $37,283,553 -$8,751,013 $66.33 39
2018 Q2 703,162 $43,297,958 -$11,884,826 $61.49 41
2018 Q1 870,433 $56,180,594 -$33,070,392 $64.54 44
2017 Q4 1,380,234 $91,916,262 -$996,391 $66.60 50
2017 Q3 1,395,701 $88,924,802 -$2,324,076 $63.72 47
2017 Q2 1,432,238 $89,673,387 +$4,709,067 $62.62 47
2017 Q1 1,357,101 $82,248,737 +$14,409,128 $60.61 45
2016 Q4 1,126,509 $66,833,000 +$30,105,345 $59.33 40
2016 Q3 624,521 $33,021,000 -$8,046,057 $52.87 31
2016 Q2 795,488 $40,270,000 +$3,112,836 $50.63 33
2016 Q1 714,949 $35,661,000 -$10,176,320 $49.90 31
2015 Q4 916,311 $46,827,000 +$2,776,322 $51.15 35
2015 Q3 862,447 $41,928,000 +$5,975,300 $48.60 38
2015 Q2 740,749 $37,444,030 -$19,760,373 $50.53 31
2015 Q1 1,136,872 $56,259,796 +$3,669,184 $49.49 31
2014 Q4 1,074,185 $53,727,158 -$1,050,401 $50.01 35
2014 Q3 812,154 $38,255,821 -$15,879,783 $47.12 33
2014 Q2 1,147,323 $54,844,804 -$778,223 $47.80 34
2014 Q1 1,167,106 $53,594,164 +$1,465,700 $45.92 32
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .